Central venous thrombolysis/PTA/stenting

Seminars in Interventional Radiology

Volumn 17, Issue 2, 2000, Pages 121-138

  Brady, T M ^a   Swischuk, J L ^a   Castaneda, F ^a   Smouse, H B ^a   Fox, P F ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

Central venous occlusion; Thrombolysis; Thrombosis

Indexed keywords

ALTEPLASE; HEPARIN; PLASMINOGEN ACTIVATOR; RETEPLASE; SILASTIC; UROKINASE; WARFARIN;

ANTICOAGULATION; ARTICLE; AXILLARY VEIN; BLEEDING; BLOOD CLOT LYSIS; CENTRAL VEIN; CLINICAL TRIAL; FIBRINOLYTIC THERAPY; HUMAN; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; STENT; SUBCLAVIAN VEIN; SUPERIOR CAVA VEIN; SUPERIOR CAVA VEIN SYNDROME; TECHNIQUE; VEIN RUPTURE; VEIN THROMBOSIS;

EID: 0033859137     PISSN: 07399529     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2000-9452     Document Type: Article

References (105)

1. Thrombosis of axillary and subclavian veins
2. Pathogenesis determines late morbidity of axillosubclavian vein thrombosis
3. AEffort thrombosis of the axillary and subclavian veins
4. Axillary-subclavian venous occlusion: The morbidity of a nonlethal disease
5. Upper-extremity deep venous thrombosis and pulmonary embolism
6. Primary subclavian vein thrombosis and pulmonary embolism
7. Upper extremity deep venous thrombosis: Underdiagnosed and potentially lethal
8. Deep venous thrombosis of the upper extremity: A reappraisal
9. Axillary, subclavian, and brachiocephalic vein obstruction
10. Natural history of major venous thrombosis of the upper extremity
11. Primary subclavian vein thrombosis and pulmonary embolism
12. Axillary and subclavian vein stenosis: Percutaneous angioplasty
13. Consequences of 'conservative' conventional management of axillary vein thrombosis
14. Primary subclavianaxillary vein thrombosis
15. Therapy and the natural course of axillary vein thrombosis: Review of 765 patients and analysis of our personal patient sample
16. Pathogenesis determines late morbidity of axillosubclavian vein thrombosis
17. Occult pulmonary embolism: A common occurrence in deep venous thrombosis
18. Unexpected high prevalence of silent pulmonary embolism in patients with deep venous thrombosis
19. Asymptomatic pulmonary embolism in patients with deep vein thrombosis: Is it useful to take a lung scan to rule out this condition?
20. Primary deep venous thrombosis of upper extremity
21. Thrombolytic therapy and surgery for primary, axillosubclavian vein thrombosis: Current approach
22. Thrombolysis of peripheral arterial bypass grafts: Surgical thrombectomy compared with thrombolysis
23. Thrombolysis with recombinant human tissue-type plasminogen activator in patients with peripheral artery and bypass graft thrombosis
24. Comparison of tPA and urokinase for peripheral arterial thrombolysis
25. Results of a prospective randomized trial evaluating surgery versus thrombolysis for ischemia of the lower extremity The STILE Trial
26. Treatment of Paget-Schroetter syndrome: A staged, multidisciplinary approach
27. Local thrombolytic therapy for subclavian and axillary vein thrombosis: Treatment of the thoracic outlet syndrome
28. Lytic therapy in the treatment of axillary and subclavian vein thrombosis
29. Longterm results of treatment for axillary subclavian vein thrombosis
30. Evaluation of a new treatment strategy for Paget-Schroetter syndrome: Spontaneous thrombosis of the axillary-subclavian vein
31. Essentials and safeguards of surgery for thoracic outlet syndrome
32. Transaxillary operative management of thoracic outlet syndrome
33. Longterm results of treatment for axillary subclavian vein thrombosis
34. Venous stent placement as an adjunct to the staged, multimodal treatment of Paget-Schroetter syndrome
35. Initial experience with venous stents in exertional axillary-subclavian vein thrombosis
36. Collapse of a Palmaz stent in the subclavian vein
37. Venous stent placement as an adjunct to the staged, multimodal treatment of Paget-Schroetter syndrome
38. DRGs and specialized nutrition support. Prospective payment and nutritional support and need for reform
39. Complications associated with central venous catheters
40. The role of catheter composition in the development of thrombophlebitis
41. Subclavian venous thrombosis due to indwelling catheters: A prospective study on 52 patients
42. Long-term follow-up of tunneled Silastic hemodialysis catheters
43. Post catheterization vein stenosis in hemodialysis: Comparative angiographic study of 50 subclavian and 50 internal jugular access
44. Superiority of the internal jugular over the subclavian access for temporary hemodialysis
45. Percutaneously inserted Silastic jugular hemodialysis catheters seldom cause jugular vein thrombosis
46. Tunneled hemodialysis catheters: Use of a silver-coated catheter for prevention of infection - A randomized study
47. Distribution and severity of stenoses in functioning arteriovenous grafts: A duplex and angiographic study
48. Superiority of the internal jugular over the subclavian access for temporary hemodialysis
49. Comparison of operative reconstruction and percutaneous balloon dilatation for central venous obstruction
50. Percutaneous transluminal angioplasty of brachiocephalic vein stenoses in patients with dialysis shunts
51. Central venous stenosis in the hemodialysis patient: Incidence and efficacy of endovascular treatment
52. The role of percutaneous angioplasty in the management of chronic hemodialysis fistulas
53. Central venous angioplasty: An exercise in futility in hemodialysis patients?
54. Axillosubclavian veins and superior vena cava
55. Use of wallstents for hemodialysis access-related venous stenoses and occlusions untreatable with balloon angioplasty
56. Insufficient dialysis shunts: Improved long-term patency rates with close hemodynamic monitoring, repeated percutaneous balloon angioplasty, and stent placement
57. Percutaneous transvenous angioplasty in the treatment of vascular access stenosis
58. Prevention of hemodialysis fistula thrombosis: Early detection of venous stenoses
59. Optimization of high-efficiency hemodialysis by detection and correction of fistula dysfunction
60. Hemodialysis grafts: Color Doppler flow imaging correlated with digital subtraction angiography and functional status
61. Physical examination of AV grafts
62. Percutaneous transluminal angioplasty of stenotic lesions in dialysis vascular accesses
63. Dialysis access fistulas: Treatment of stenoses by transluminal angioplasty
64. The role of percutaneous angioplasty in the management of chronic hemodialysis fistulas
65. Insufficient hemodialysis access fistulas: Late results of treatment with percutaneous balloon angioplasty
66. Percutaneous transluminal angioplasty of arteriovenous shunts
67. Complications from permanent hemodialysis vascular access
68. Malpractice issues in radiology: Off-label use of interventional medical devices
69. Venous stenoses in patients who undergo hemodialysis: Treatment with self-expandable endovascular stents
70. Vena caval anc central venous stenoses: Management with Palmaz balloon-expandable intraluminal stents
71. Use of the Palmaz balloon-expandable stent in subclavian/brachiocephalic vein stenosis [abstr]
72. Collapse of a Palmaz stent in the subclavian vein
73. Venous stenoses in patients who undergo hemodialysis: Treatment with self-expandable endovascular stents
74. Modifications of Gianturco expandable wire stents
75. Stents in hemodialysis fistulas and grafts
76. Venous stenosis and occlusion in hemodialysis shunts: Follow-up results of stent placement in 65 patients
77. Thrombolytic therapy for catheter-related thrombosis
78. Local infusion of urokinase for the lysis of thrombosis associated with permanent central venous catheters in cancer patients
79. Subacute and chronic benign superior vena cava obstructions: Endovascular treatment with self-expanding metallic stents
80. Long-term results of treatment of benign central venous obstructions unrelated to dialysis with expandable Z stents
81. Etiologic considerations in SVC syndrome
82. Management of superior vena caval syndrome
83. Obstruction of superior vena cava
84. Bypass of superior vena cava: Fifteen years' experience with spiral vein grafts for obstruction of superior vena cava caused by benign disease
85. Percuataneous treatment of superior vena caval syndrome
86. Gianturco self-expanding stents: Clinical experience in the vena cava and large veins
87. Gianturco-Rosch expandable Z-stents in the treatment of superior vena cava syndrome
88. Use of the Gianturco self-expanding stent in stenoses of the superior and inferior venae cavae
89. Expandable metal stents for stenoses of the venae cavae and large veins
90. Stenosis of the vena cava: Preliminary assessment of treatment with expandable metallic stents
91. Vena caval and central venous stenoses: Management with Palmaz balloon-expandable intraluminal stents
92. Percutaneous treatment of venous occlusive disease with stents
93. Migration of Palmaz stents following deployment for venous stenoses realted to hemodialysis access
94. Stenting in malignant obstruction of superior vena cava
95. Gianturco self-expanding stents: Clinical experience in vena cava and large veins
96. Intervascular stents in the management of superior vena cava syndrome
97. Expandable wall stent for the treatment of obstruction of the superior vena cava
98. The use of Wallstent endovascular prosthesis in the treatment of superior vena caval obstruction
99. Venous rupture complicating hemodialysis access angioplasty: Percutaneous treatment and outcomes in seven patients
100. Treatment of hemodialysis access rupture during PTA with Wallstent implantation
101. Wallstent deployment to salvage dialysis graft thrombolysis complicated by venous rupture: Early and intermediate results
102. Treatment of hemodialysis-related central venous stenosis or occlusion: Results of primary Wallstent placement and follow-up in 50 patients